Regaal Resources Reports Q1 FY26 Revenue Up 26.5% YoY to ₹246.57 Crore; Plans Capacity Expansion
The announcement includes the company's first post-listing financial results, details on the utilization of IPO funds, and significant future guidance on capacity expansion and new product introductions, all of which are critical for investors and indicate strategic growth.
The company reported robust revenue growth, is actively utilizing IPO proceeds for debt reduction, and has laid out clear, ambitious plans for capacity expansion and new product launches, indicating a positive outlook despite some margin contraction in the current quarter.
Regaal Resources Limited (RRL) announced its unaudited financial results for the first quarter ended June 30, 2025, reporting: * Total income stood at ₹2,468.3 Mn (₹246.83 crore) for Q1 FY26, marking a growth of 26.3% year-over-year (YoY). * Revenue from operations increased by 26.5% YoY to ₹2,465.7 Mn (₹246.57 crore). * Operating EBITDA was ₹244.7 Mn (₹24.47 crore), up by 2.2% YoY, with an Operating EBITDA Margin of 9.9%. * Profit After Tax (PAT) stood at ₹90.7 Mn (₹9.07 crore), down by 1.2% YoY, with a PAT Margin of 3.7%. * Diluted EPS was ₹1.09, an 8.9% decline YoY. * Value Add for Q1 FY26 was ₹618.1 Mn (₹61.81 crore), with a margin of 25.1%, reflecting a 400 basis points YoY decline. This contraction was primarily due to elevated maize procurement costs in March 2025, impacting input costs for Q1 FY26, and an 8-day shutdown in June 2025 for repair and maintenance.
Mr. Anil Kishorepuria, Chairman & Managing Director, commented on the results: * Expressed gratitude for the IPO response and confirmed the utilization of net IPO proceeds of ₹1,871.4 Mn (₹187.14 crore) towards debt reduction. * Noted the robust growth in Operating Income and expressed optimism for the second half of the year, supported by stabilizing raw material costs and healthy demand. * Outlined future plans to scale crushing capacity from 825 TPD (as of June 2025) to 1,650 TPD by the end of Q4 FY26. * Announced intentions to introduce new derivatives such as Maltodextrin, Liquid Glucose, DAH, and DMH, alongside an expanded range of modified starches and high-value derivatives to capture rising demand and enhance margins.
What to do with a filing like this
Regaal Resources Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Regaal Resources Limited. Read the original for the full detail.